In another study, Kong et al. [156] showed that zebularine and TSA with TRAIL (TZT) treatment sensitizes human breast adenocarcinoma cells (MDA-MB-231 and MCF10A) and augments apoptosis as compared with TRAIL alone. Here, TNFSF10 is linked to breast adenocarcinoma.